141 related articles for article (PubMed ID: 4144240)
21. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
22. Effects of formoterol (BD 40A), a beta-adrenoceptor stimulant, on isolated guinea-pig lung parenchymal strips and antigen-induced SRS-A release in rats.
Tomioka K; Yamada T; Tachikawa S
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):91-102. PubMed ID: 6202254
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamics of a new selective beta2-adrenergic bronchodilator 3-(4-methoxybenzylamino)-4-hydroxy-alpha-(tert. butylaminomethyl)-benzyl-alcohol, HCl (QH25).
Larsen JJ; Hermansen K
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):42-64. PubMed ID: 576362
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of RO363, a beta1-adrenoceptor selective agonist.
Iakovidis D; Malta E; McPherson GA; Raper C
Br J Pharmacol; 1980 Apr; 68(4):677-85. PubMed ID: 6103722
[TBL] [Abstract][Full Text] [Related]
25. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
26. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
Daemmgen JW; Engelhardt G; Pelzer H
Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
[TBL] [Abstract][Full Text] [Related]
27. Effects of beta-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle: in vitro and in vivo results compared.
Olsson OA; Swanberg E; Svedinger I; Waldeck B
Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):272-6. PubMed ID: 34976
[TBL] [Abstract][Full Text] [Related]
28. Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat.
Bowman WC; Rodger IW
Br J Pharmacol; 1972 Aug; 45(4):574-83. PubMed ID: 5085231
[TBL] [Abstract][Full Text] [Related]
29. Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
Naline E; Trifilieff A; Fairhurst RA; Advenier C; Molimard M
Eur Respir J; 2007 Mar; 29(3):575-81. PubMed ID: 17135231
[TBL] [Abstract][Full Text] [Related]
30. The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations.
Yabuuchi Y
Br J Pharmacol; 1977 Dec; 61(4):513-21. PubMed ID: 23191
[TBL] [Abstract][Full Text] [Related]
31. Adrenergic agents. 1. Synthesis and potential beta-adrenergic agonist activity of some catecholamine analogs bearing a substituted amino functionality in the meta position.
Kaiser C; Colella DF; Schwartz MS; Garvey E; Wardell JR
J Med Chem; 1974 Jan; 17(1):49-57. PubMed ID: 4148422
[No Abstract] [Full Text] [Related]
32. Beta-adrenoreceptors in denervated skeletal muscles of the cat.
Bohmer K; Raper C
Clin Exp Pharmacol Physiol; 1975; 2(3):239-48. PubMed ID: 238777
[TBL] [Abstract][Full Text] [Related]
33. Catechol-substituted phenoxypropanolamines: adrenoceptor activity in the anaesthetized cat.
Dowd H; Keh GS; Raper C
Br J Pharmacol; 1977 Jun; 60(2):197-203. PubMed ID: 880431
[TBL] [Abstract][Full Text] [Related]
34. The effect of nipradilol on the isoproterenol-induced depression of contractions in the cat soleus muscle.
Tanaka T; Murata N; Yamauchi Y
Jpn J Pharmacol; 1999 Nov; 81(3):286-91. PubMed ID: 10622217
[TBL] [Abstract][Full Text] [Related]
35. Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle.
Bowman WC; Nott MW
Br J Pharmacol; 1970 Jan; 38(1):37-49. PubMed ID: 4391735
[TBL] [Abstract][Full Text] [Related]
36. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
38. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
Engelhardt G
Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
[TBL] [Abstract][Full Text] [Related]
39. The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.
Daly MJ; Flook JJ; Levy GP
Br J Pharmacol; 1975 Feb; 53(2):173-81. PubMed ID: 238697
[TBL] [Abstract][Full Text] [Related]
40. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
